Cincinnati, Ohio, United States
I design enterprise strategies that reduce medical drug trend and improve reimbursement performance across specialty, biosimilar, and gene therapy categories. Over the past 15+ years, I’ve led drug pricing, drug manufacturer and provider contracting, and specialty pharmacy transformation initiatives across national health plans including CVS Health, UnitedHealthcare, and Anthem. My work has delivered: – Multi-year drug trend reductions – Enterprise-wide reimbursement improvements – Site-of-care optimization strategies – Vendor, drug manufacturer, and specialty pharmacy contract restructuring I specialize in solving complex, high-cost drug management challenges that impact payer profitability, employer group affordability, and provider network sustainability. If you are navigating: – Escalating medical drug trend – Biosimilar adoption and savings strategy – Specialty pharmacy channel misalignment – Vendor contracting inefficiencies I bring strategic clarity and execution discipline to drive measurable financial impact.
Lead manufacturer strategy for medical specialty drug, biosimilar, and gene therapy management impacting national payer drug savings performance and long-term drug trend control.
Led enterprise drug pricing and reimbursement contracting strategies across hospital, physician office, specialty pharmacy, and home infusion channels, delivering multi-year medical drug cost reductions.
Led team responsible for creating and implementing Anthem enterprise specialty pharmacy program initiatives engaging both internal health plans and external specialty pharmacy providers to drive improvements in cost of care, clinical effectivenss, or operational efficiency. Responsible for enterprise specialty pharmacy vendor contracts development and oversight. Lead enterprise specialty site of care drug utilization channel management solutions
Responsible for developing WellPoint enterprise specialty pharmacy strategy and programs that have pharmacy and medical benefit cost-of-care spend impact. Provide oversight for the execution of all enterprise approved initiatives via leading enterprise SpecialtyRx council and supporting committees. Responsible for developing integrated specialty pharmacy strategies with contracted specialty pharmacy vendors that yield cost of care savings and maxmize clinical and operational WellPoint member experience.
Led enterprise pharmacy benefit management and specialty pharmacy operation programs. Programs focused on revenue/membership growth and/or re-engineering specialty pharmacy operatons. Upon WellPoint sale of company owned PBM and specialty pharmacy, led WellPoint enterprise initiatives that yielded integrated WellPoint health plan and specialty pharmacy solutions. Established infrastructure for integrated solutions for long-term partnership with contracted specialty pharmacy vendor.
Led blue-chip project and program initiatives that yielded pharmacy multi-million dollar revenue and membership growth.
Provided governance oversight of approved portfolio health care system-wide project initiatives. Led initiatives to enhance the strategic and tactical use of program/project management process and resources across the Health Alliance.